These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24657963)

  • 1. Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.
    Fink KD; Crane AT; Lévêque X; Dues DJ; Huffman LD; Moore AC; Story DT; Dejonge RE; Antcliff A; Starski PA; Lu M; Lescaudron L; Rossignol J; Dunbar GL
    Stem Cells Transl Med; 2014 May; 3(5):620-31. PubMed ID: 24657963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.
    Mu S; Wang J; Zhou G; Peng W; He Z; Zhao Z; Mo C; Qu J; Zhang J
    PLoS One; 2014; 9(7):e101185. PubMed ID: 25054283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
    Reynolds DS; Carter RJ; Morton AJ
    J Neurosci; 1998 Dec; 18(23):10116-27. PubMed ID: 9822765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats.
    Badini F; Bayrami A; Mirshekar MA; Shahraki S; Fanaei H
    Behav Brain Res; 2024 Mar; 461():114864. PubMed ID: 38220060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats.
    Katariya R; Mishra K; Sammeta S; Umekar M; Kotagale N; Taksande B
    Neurotoxicology; 2024 May; 102():12-28. PubMed ID: 38453033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington's disease.
    Shehata NI; Abd El-Salam DM; Hussein RM; Rizk SM
    PLoS One; 2023; 18(11):e0293660. PubMed ID: 37910529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's Disease.
    Chakraborty J; Singh R; Dutta D; Naskar A; Rajamma U; Mohanakumar KP
    CNS Neurosci Ther; 2014 Jan; 20(1):10-9. PubMed ID: 24188794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats.
    Wells RG; Azzam AF; Hiller AL; Sardinia MF
    J Huntingtons Dis; 2024; 13(1):55-66. PubMed ID: 38489193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of levothyroxine on cognition deficits and memory in an experimental model of Huntington's disease in rats: An electrophysiological study.
    Badini F; Mirshekar MA; Shahraki S; Fanaei H; Bayrami A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5939-5951. PubMed ID: 38372755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
    Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
    J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of human cord blood-derived extracellular vesicles by improved neuromuscular function and reduced gliosis in a rat model of Huntington's disease.
    Bahar R; Darabi S; Norouzian M; Roustaei S; Torkamani-Dordshaikh S; Hasanzadeh M; Vakili K; Fathi M; Khodagholi F; Kaveh N; Jahanbaz S; Moghaddam MH; Abbaszadeh HA; Aliaghaei A
    J Chem Neuroanat; 2024 Jul; 138():102419. PubMed ID: 38609056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington's disease.
    Islam J; So KH; Kc E; Moon HC; Kim A; Hyun SH; Kim S; Park YS
    Stem Cell Res Ther; 2021 Nov; 12(1):585. PubMed ID: 34809707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Neurodevelopmental Abnormalities in iPSC-Derived Striatal Cultures from Patients with Huntington's Disease.
    Mathkar PP; Suresh D; Dunn J; Tom CM; Mattis VB
    J Huntingtons Dis; 2019; 8(3):257-269. PubMed ID: 31381521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease.
    Palfi S; Ferrante RJ; Brouillet E; Beal MF; Dolan R; Guyot MC; Peschanski M; Hantraye P
    J Neurosci; 1996 May; 16(9):3019-25. PubMed ID: 8622131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?
    Precious SV; Zietlow R; Dunnett SB; Kelly CM; Rosser AE
    Neurochem Int; 2017 Jun; 106():114-121. PubMed ID: 28137534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute effects of 3-nitropropionic acid on the behavior and spontaneous cortical electrical activity of rats.
    Lukács A; Szabó A; Vezér T; Papp A
    Acta Neurobiol Exp (Wars); 2006; 66(3):227-33. PubMed ID: 17133954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cells for Huntington's Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington's Disease.
    SC4HD Consortium
    J Huntingtons Dis; 2021; 10(2):221-226. PubMed ID: 33814456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rat model of hemidystonia induced by 3-nitropropionic acid.
    Liu HG; Ma Y; Meng DW; Yang AC; Zhang JG
    PLoS One; 2013; 8(10):e79199. PubMed ID: 24194961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing stem cell therapies for juvenile and adult-onset Huntington's disease.
    Fink KD; Deng P; Torrest A; Stewart H; Pollock K; Gruenloh W; Annett G; Tempkin T; Wheelock V; Nolta JA
    Regen Med; 2015; 10(5):623-46. PubMed ID: 26237705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotent stem cells models for Huntington's disease: prospects and challenges.
    Carter RL; Chan AW
    J Genet Genomics; 2012 Jun; 39(6):253-9. PubMed ID: 22749012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.